This article is more than 5 years old. Information may no longer be current.
Association of Community Cancer Centers names award recipients
Click Here to Manage Email Alerts
The Association of Community Cancer Centers will honor several award recipients at its national conference this fall.
Barbara L. McAneny, MD, FASCO, MACP, will receive the Annual Achievement Award, which recognizes distinguished individuals or organizations whose contributions to the field reflect the values of community cancer care.
McAneny, a medical oncologist who is CEO and one of two founding partners of New Mexico Cancer Center, will become president of the AMA in June 2018.
McAneny, the first oncologist to serve as AMA president, received an award in 2012 from the Centers for Medicare and Medicaid Innovation to test how oncology private practices could provide better care at a lower cost. That award helped lead to the creation of Medicare’s Oncology Care Model.
Raymond U. Osarogiagbon, MBBS, FACP, director of the multidisciplinary thoracic oncology program at Baptist Cancer Center in Memphis, Tennessee, will receive the Clinical Research Award. The award recognizes individuals whose research has had a significant positive effect on patients with cancer, their families or the community.
Osarogiagbon’s research focuses on improving population-based systems of care and accuracy of cancer staging, as well as assessing the biologic drivers of outcome differences in patients with potentially curable lung cancer.
The clinical research team at Sanford Health in Sioux Falls, South Dakota, will receive the David King Community Clinical Scientist Award. The award recognizes active community clinical research leaders who demonstrated leadership in the development, participation and evaluation of clinical studies or are active in the development of new risk assessment, screening, treatment or supportive care programs for patients with cancer.
Sanford Health is the largest rural, not-for-profit health care system in the country. It includes 45 hospitals and 289 clinics in nine states and three countries. The system offers 350 ongoing clinical studies and 150 open clinical trials, including 24 trials designed to evaluate immunotherapies for cancer.
The award recipients will be recognized during the Association of Community Cancer Centers’ National Oncology Conference, which will be held Oct. 18-20 in Nashville, Tennessee.